Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-04

Clinical Trial Update: Psilocybin Therapy in Advanced Cancer [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for psilocybin therapy in advanced cancer. The study spans Phase 2 and Phase 3 and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: NYU Langone Health | Conditions: Advanced Cancer | Phase 2, Phase 3 | Status: RECRUITING